Your browser doesn't support javascript.
loading
In vivo metabolic imaging identifies lipid vulnerability in a preclinical model of Her2+/Neu breast cancer residual disease and recurrence.
Madonna, Megan C; Duer, Joy E; McKinney, Brock J; Sunassee, Enakshi D; Crouch, Brian T; Ilkayeva, Olga; Hirschey, Matthew D; Alvarez, James V; Ramanujam, Nirmala.
Afiliação
  • Madonna MC; Department of Biomedical Engineering, Duke University, Durham, NC, USA. megan.madonna@duke.edu.
  • Duer JE; Duke University Trinity College of Arts and Sciences, Durham, NC, USA.
  • McKinney BJ; Department of Pharmacology & Cancer Biology, School of Medicine, Duke University, Durham, NC, USA.
  • Sunassee ED; Department of Biomedical Engineering, Duke University, Durham, NC, USA.
  • Crouch BT; Department of Biomedical Engineering, Duke University, Durham, NC, USA.
  • Ilkayeva O; Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Durham, NC, USA.
  • Hirschey MD; Department of Pharmacology & Cancer Biology, School of Medicine, Duke University, Durham, NC, USA.
  • Alvarez JV; Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Durham, NC, USA.
  • Ramanujam N; Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition, Duke University Medical Center, Durham, NC, USA.
NPJ Breast Cancer ; 8(1): 111, 2022 Sep 26.
Article em En | MEDLINE | ID: mdl-36163365

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: NPJ Breast Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos